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Abstract
 
B cell tolerance or autoimmunity is determined by selective events. Negative selection of self-
reactive B cells is well documented and proven. In contrast, positive selection of conventional B
cells is yet to be firmly established. Here, we demonstrate that developing self-reactive B cells are
not always highly sensitive to the deletion mechanisms imposed by membrane-bound self-antigens.
At low amounts, membrane-bound antigens allow survival of B cells bearing a single high affinity
self-reactive B cell receptor (BCR). More importantly, we show that forced allelic inclusion
modifies B cell fate; low quantities of self-antigen induce the selection and accumulation of
increased numbers of self-reactive B cells with decreased expression of antigen-specific BCRs.
By directly measuring antigen binding by intact B cells, we show that the low amounts of self-
antigen select self-reactive B cells with a lower association constant. A fraction of these B cells is
activated and secretes autoantibodies that form circulating immune complexes with self-antigen.
These findings demonstrate that conventional B cells can undergo positive selection and that the
fate of a self-reactive B cell depends on the quantity of self-antigen, the number of BCRs engaged,
and on its overall antigen-binding avidity, rather than on the affinity of individual BCRs.
Key words: B lymphocytes • self-reactivity • avidity • selection • self-antigen
 
Introduction
 
B cell repertoires are determined by different selective events
(1). In transgenic mice expressing hen egg lysozyme (HEL) as
a neo self-antigen, B cells transgenic for a high affinity B cell
receptor (BCR) specific for HEL undergo different fates (2,
3). When HEL was expressed in membrane form, HEL-
specific B cells were deleted early on ontogeny (3). When
HEL was expressed in a soluble form, HEL-specific B cells
were not deleted, but became unable to proliferate or secrete
HEL-specific antibodies (2). Based on these results, it was
postulated that B cell deletion required BCR cross-linking
and could only be induced by membrane bound self-antigens.
In contrast, soluble self-antigens could not induce negative
selection, but only induced anergy. Studies on the fate of B
cells expressing anti-MHC class I BCRs supported the role
of receptor cross-linking in B cell deletion (4, 5) and showed
that deletion of self-reactive B cells could also occur in the
peripheral lymphoid tissues (5, 6). In contrast to T cells (7),
positive selection of conventional B cells is not yet estab-
lished. B cell positive selection has been shown only for a
subpopulation of peritoneal B1 B cells (8). However, it is
unlikely that conventional B cells do not undergo positive
selection. Induced ablation of the BCR leads to rapid B cell
death (9), demonstrating that B cells require BCR-mediated
survival signals, either constitutive or given through their
interaction with yet unknown ligands (10). The V gene usage
skewing between immature BM and mature peripheral B
cells further supports the role of positive selection in shaping
B cell repertoires (11–13). The absence of papers demon-
strating directly positive selection of conventional B cells may
be due to the high affinity of the BCR interactions (com-
pared with TCRs), which may hamper positive selection
events. Recent works have shown that self-reactive B cells
may escape deletion by either down-regulating the overall
 
surface expression of BCRs (14, 15) or diluting the self-
reactive BCR through the expression of two BCRs (16).
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The role of the dose of antigen in B cell selection is also
unknown. We may assume that to have a positive selection
event, it suffices that one lymphocyte interacts with its spe-
cific ligand and receives survival signals. In contrast, to at-
tain negative selection, that is, to expurgate a repertoire of a
particular specificity, it is required that all lymphocytes
bearing that specificity interact with antigen and receive
death signals. Thus, the quantities of self-antigen may play
a major role in the selection of B cell repertoires. Indeed,
the probability of positive selection increases if the concen-
tration of ligand favors its encounter with the rare specific
cells, whereas negative selection can only be achieved if the
quantities of antigen are sufficiently high to be met by all
developing high affinity self-reactive cells. Previous studies
have suggested that tolerance induction of self-reactive B
cells was not achieved if soluble self-antigen was present
below a certain concentration (17). However, the precise
role of the quantity of self-antigens in B cell development
and selection was not completely characterized.
To address these questions, we revisited the mouse model
in which HEL-specific B cells develop in the presence of the
neo self-antigen HEL (2, 3), but designed new experimental
strategies to reduce self-antigen expression and/or B cell
binding avidity for antigen. Our results show that mem-
brane-bound self-antigen does not always induce B cell de-
letion; different types of B cell tolerance can be induced de-
pending of the dose of self-antigen. Moreover, we estimated
the antigen association constant of the intact self-reactive B
cell, and showed that reduction of the B cell K
 
a
 
 (by forced
allelic inclusion) modifies B cell fate. Low quantities of self-
antigen mediate positive selection of conventional B cells
and activate self-reactive B cells with a low K
 
a
 
 to secrete au-
toantibodies. In conclusion, like T cells, conventional B cells
can undergo positive selection events. The quantity of self-
antigen and the overall antigen-binding capacity of the cell
determine the final fate of the self-reactive B cell.
 
Materials and Methods
 
Mice and Bone Marrow Chimeras. 
 
C57BL/6.Rag2-deficient
mice  (18) were obtained from the Centre Des Techniques
Avancées, Centre Nationale de la Recherche Scientifique. The
following lines of transgenic mice were used: MoMD4.Rag2
 
 
 
/
 
 
 
(
 
  
 
HEL; reference 2), MoSP6.Rag2
 
 
 
/
 
 
 
 (
 
  
 
TNP; reference
19), MoMD4.MoSP6.Rag2
 
 
 
/
 
 
 
(DIgTg; reference 20), B6.ML5.
Rag2
 
 
 
/
 
 
 
(sHEL; reference 2), and B6.KLK3.Rag2
 
 
 
/
 
 
 
(mHEL;
reference 3). All transgenic lines in the C57Bl/6.Rag2-deficient
background were kept specifically pathogen-free at the Centre
Des Techniques Avancées. 8-wk-old Rag2
 
 
 
/
 
 
 
 mice were lethally
irradiated with 950 rad from a 
 
135
 
Cs source. Each host received
i.v. 4 
 
 
 
 10
 
6
 
 BM cells as indicated in the Results section. Donor
cells were depleted of mature B cells using a Dynal MPC6 or Au-
toMacs (Miltenyi Biotec) magnetic sorter, and BM cells were in-
cubated with anti-IgM biotinylated antibodies followed by
streptavidin-coated Dynabeads. Chimeras were killed 6 wk after
reconstitution, and the number and phenotype of BM pre–B and
B cells, spleen B cells, and the serum IgM concentrations were
evaluated. In the sHEL Tg donor mice, HEL is present exclu-
sively in soluble form at 
 
 
 
20 ng/ml of serum. In the mixed sHEL
 
BM chimeras, the serum amounts of HEL were below the 0.1
ng/ml detection level (not depicted) and we estimated the frac-
tion of HEL-producing cells in each chimera by semi-quantitative
PCR using primers specific for the HEL transgene (unpublished
data). In the mHEL Tg donor mice, HEL (expressed under the
control of the MHC class I H-2K
 
b
 
 promoter; reference 2) is
present on the surface of all cells and shed to reach concentrations
of 200–300 ng/ml in the serum (21). Thus, in the mHEL chime-
ras, quantification of antigen-expressing cells could be assessed ei-
ther by ELISA or flow cytometry.
 
Flow Cytometry Analysis. 
 
Cells were stained with combina-
tions of FITC, PE, allophycocyanin, or biotin-labeled antibodies,
followed by streptavidin PerCP or streptavidin-allophycocyanin
(Caltag). Monoclonal antibodies RA3-6B2 (anti-B220), S7 (anti-
CD43), R6-60.5 (anti-IgM), 493, 1D3 (anti-CD19), 7G6 (anti-
CD21), and B3B4 (anti-CD23) were obtained from BD Bio-
sciences and 11-26 (anti-IgD) was obtained from Southern
Biotechnology Associates, Inc. Cells expressing the 
 
 
 
-HEL BCR
Tg were identified by first incubating the cells with 500 ng/ml
HEL (Sigma-Aldrich) followed by a labeled monoclonal anti-
HEL mouse 
 
 
 
1 antibody. Lymphocytes expressing transgenic
 
 
 
-TNP BCR were identified with the 20.5 antibody, a BALB/c
 
 
 
1 anti-SP6 idiotype that also recognizes the SP6 
 
 
 
-TNP IgH
chain in association with other unrelated light chains. Dead cells
were excluded from analysis by propidium iodide gating. All
analyses were performed on a FACScalibur™ (Becton Dickin-
son) interfaced to a Macintosh CELLQuest™ program. Student’s
 
t
 
 test was used for statistical analysis of cell numbers. Probabilities
of P 
 
  
 
0.05 and P 
 
  
 
0.01 were considered significant.
 
BrdU Labeling. 
 
Groups of mice received two daily i.p. injec-
tions of 1 mg bromodeoxyuridine (BrdU; Sigma-Aldrich) at 12-h
intervals for 1 or 3 consecutive days. Surface-stained BM and
spleen cells were fixed in PBS containing 1% paraformaldehyde
and 0.01% Tween 20 for 48 h, and were treated with DNase I
(Roche) for BrdU detection with a FITC-conjugated anti-BrdU
antibody (Becton Dickinson) as described previously (22). Fixation
and DNase treatment restricted the usage of certain surface staining
combinations for the analysis of the BrdU-labeled cell populations.
 
ELISA. 
 
IgM and HEL serum concentrations were quanti-
fied by ELISA. Plates were coated with antibodies either to total
IgM, IgM
 
a
 
, 20.5, or HEL and saturated with PBS-5% milk. Dilu-
tions of sera were added. After incubation (1–6 h, 37
 
 
 
C) and
washing, biotin-labeled anti–mouse IgM or anti-HEL Abs were
added. Bound antibodies were revealed with peroxidase-labeled
avidin followed by the substrate 
 
O
 
-phenylenediamine and H
 
2
 
O
 
2
 
.
The reaction was stopped after 10 min by 10% SDS and the ab-
sorbance was read at 450 nm in a titertek multiscan spectrometer
(Flow Laboratories). Titration of serum IgM and HEL was per-
formed using as standard purified mouse IgM (Southern Biotech-
nology Associates, Inc.) or HEL (Sigma-Aldrich). Concentrations
were determined by comparing the displacement of the dilution
curves in the linear interval between standards at a concentration
of 1 mg/ml (IgM) and 30 ng/ml (HEL), respectively, and the se-
rum samples. For the detection of HEL–IgM immune com-
plexes, plates were coated with antibodies to HEL and saturated.
Dilutions of sera were added. After incubation (6 h, 37
 
 
 
C) and
washing, the HEL-bound IgMs were revealed by adding biotin-
labeled anti–mouse IgM antibodies followed by peroxidase-
labeled avidin, the substrate 
 
O
 
-phenylenediamine, and H
 
2
 
O
 
2
 
.
The reaction was stopped as aforementioned.
 
[
 
125
 
I]HEL-binding Assays. 
 
HEL was labeled with 
 
125
 
I as de-
scribed previously (23). Before each assay, the specific activity
(cpm/
 
 
 
g of [
 
125
 
HEL]) was measured. Saturation of the HEL-spe- 
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cific BCRs was studied in triplicate by incubating 10
 
6
 
 spleen cells
for 1 h at 4
 
 
 
C with increasing doses (from 0 to 250 ng) of
 
125
 
HEL. The plateau of radioactive HEL binding was measured
and the 50% binding concentration [
 
125
 
HEL] 
 
50%
 
 was determined
for each cell type. The number of HEL molecules bound by each
cell and the number of BCRs per cell was evaluated. Competi-
tion assays were performed by incubating 10
 
6
 
 cells with a mix of
[
 
125
 
HEL] 
 
50%
 
 and increasing concentrations of unlabeled HEL.
Binding data were fitted with the four-parameter logistic model
of the Hill equation: Y 
 
 
 
 Ym 
 
 
 
 (Yo 
 
 
 
 Ym)/(1 
 
  
 
(X/I
 
50
 
)
 
p
 
),
with a software based on a nonlinear fitting algorithm. I
 
50
 
 is the
concentration of the unlabeled HEL competitor at which, at
equilibrium, 50% of the binding is inhibited, and thus represents
the dissociation constant Kd. The reciprocals of Kd values, K
 
a
 
 
 
 
 
1/Kd, are the association constants at equilibrium. With a popu-
lation of structurally heterogeneous cell receptors, this calculated
K
 
a
 
 represents the average affinity constant of the interactions with
HEL (the overall avidity of the cells for HEL). These represent an
approximate quantitative measure of the interaction between in-
tact HEL-specific B cells with HEL. These measures should be
necessarily different from the affinity determinations made for the
isolated purified monoclonal HEL-specific IgG antibodies used to
produce MD4 Tg mice.
 
Results
 
Experimental Strategy.
 
We designed an experimental
strategy in which a homogeneous population of antigen-
specific B cells develops in the presence of different
amounts of self-antigen. We used lethally irradiated im-
mune-deficient Rag2
 
 
 
/
 
 
 
 host mice reconstituted with a
mixture of BM cells containing precursors for both anti-
gen-specific 
 
 
 
-HEL B cells and HEL antigen-producing
cells. In brief, 50% of the injected BM cells were from
Rag2
 
 
 
/
 
 
 
 donors Tg for a HEL-specific BCR (
 
 
 
-HEL).
These BM cells from the 
 
 
 
-HEL donors were depleted of
mature B cells to ensure we were injecting only immature
precursors. By keeping the fraction of HEL-specific pre-
cursor cells in the injected BM cohort constant at 50%, the
number of B cell progenitors and the rate of production of
the HEL-specific B cells was the same in all chimeras stud-
ied (24). Consequently, all chimeras should have the same
number of HEL-specific B cells (24). The remaining 50%
BM cells injected were from non-Tg Rag2
 
 
 
/
 
 
 
 and HEL-
Tg Rag2
 
 
 
/
 
 
 
 mice producing a membrane form of HEL
(mHEL; reference 3) mixed at different ratios (25). By us-
ing all host and donor mice in the Rag2
 
 
 
/
 
 
 
 background,
the only lymphocytes present in the chimeras were the
HEL-specific B cells developing from the BCR Tg BM
precursors. By modifying the proportions of HEL-produc-
ing cells in the remaining 50% Rag2
 
 
 
/
 
 
 
 BM inoculum, we
changed the amount of self-antigen produced. In the re-
sulting chimeras, the fraction of mHEL-expressing hemato-
poietic-derived cells varied according to the fraction of
HEL Tg cells present in the initial BM inoculum (unpub-
lished data). The quantities of HEL present in the serum of
the different mHEL chimeras were lower than found in the
original Tg donor mice and varied between the different
groups of chimeras (Table I). In these chimeras, the HEL
antigen is discretely distributed and its quantities may vary
with tissue localization and with time, even as a result of B
cell maturation and effector functions (26) as in normal
physiology. In conclusion, we have chimeras that are HEL
free, chimeras with varying numbers of mHEL-producing
cells, and with detectable lower or higher quantities of
HEL in the serum.
 
Selection of High Avidity HEL-specific B Cells in the Presence
of Different Quantities of mHEL-producing Cells.
 
We studied
the development of a population of monoclonal B cells ex-
pressing the high affinity 
 
 
 
-HEL–specific BCR in chimeras
expressing different quantities of mHEL and in sHEL hosts.
It was described previously that in (
 
 
 
HEL 
 
 
 
 mHELTg)F1
mice, the presence of mHEL deletes all 
 
 
 
-HEL–specific B
cells (3). In the mHEL hosts reconstituted with B cell–
depleted BM cells from 
 
 
 
-HEL Tg donors, where all host
MHC class I
 
 
 
 cells express HEL, the 
 
 
 
-HEL B cells were
promptly deleted (Fig. 1 A). In the chimeras injected with
50% mHEL BM, where 50% of the hematopoietic-derived
cells express HEL, the number of B cells in the spleen was
also considerably reduced (Fig. 1 A). However, when reduc-
ing the fraction of HEL-expressing cells, we progressively in-
creased the number of B cells recovered in the peripheral
pools. In chimeras receiving 
 
 
 
5% mHEL BM cells, no B
cell deletion was observed; the number of 
 
 
 
-HEL B cells
was similar to that found in chimeras not expressing the HEL
self-antigen. In sHEL hosts, B cells were present in the BM
(not depicted) and rare in the spleen (Fig. 1 A).
We evaluated anti-HEL IgM secretion in the same chi-
meras. In the mHEL hosts or in the 50% mHEL chimeras
in which B cells were rare in the spleen, serum IgM was
barely detectable (Fig. 1 B). However, we found that the
 
Table I. 
 
HEL Concentrations in the Serum of the Mixed 
Chimeras Reconstituted with a Variable Fraction of BM Cells 
from HEL Tg Donors
 
   mHEL chimeras
Control
HEL
 
 
 
0.05%
mHEL
0.5% 
mHEL
5% 
mHEL
10% 
mHEL
25% 
mHEL
50% 
mHEL
 
 
 
0.1
 
 
 
0.1 0.29 8.96 13.13 75.29 105.73
 
 
 
0.1
 
 
 
0.1 0.48 7.48 14.06 83.12 95.79
 
 
 
0.1
 
 
 
0.1 0.30 10.15 11.18 86.80 110.40
 
 
 
0.1
 
 
 
0.1 0.38 9.90 12.05 76.69 103.70
 
 
 
0.1
 
 
 
0.1 0.39 11.53 12.07 78.12 118.10
Non-Tg Rag2
 
 
 
/
 
 
 
 host mice were irradiated and reconstituted with a
mixture of 50% BM cells from 
 
 
 
HEL donors and 50% BM cells from
Rag2
 
 
 
/
 
 
 
 and mHEL.Rag2
 
 
 
/
 
 
 
 Tg donors mixed at different ratios. 6–8
wk after reconstitution, the serum HEL concentrations were measured
by ELISA. Values represent the HEL concentration (ng/ml) in the
serum of individual chimeras. HEL concentrations in sHEL.Rag2
 
 
 
/
 
 
 
and mHEL.Rag2
 
 
 
/  transgenic donors and hosts were  26   2.73 ng/ml
and 285   11.45 ng/ml, respectively. Control mice were non-Tg
Rag2 /  host mice reconstituted with 50% BM cells from  HEL donors
and 50% BM cells from Rag2 /  donors; that is, they were HEL free. Positive Selection of Self-reactive B Cells 846
IgM levels were not always proportional to the number of
B cells. This was evident in mice containing 5 or 0.5%
mHEL BM-derived cells. In the 5% mHEL chimeras, B
cells were not deleted, but the IgM serum levels were as
low as in the 50% mHEL chimeras. These results suggest
that reduced frequencies of mHEL-expressing cells can in-
duce a state of functional anergy rather than deletion. In
these chimeras, peripheral B cells were IgMlowIgD  (un-
published data), a phenotype compatible with a state of an-
ergy (2). The results obtained in mice injected with 0.5%
mHEL BM cells were even more surprising. In these mice,
B cell numbers were normal and expressed an immature
CD23loCD21lo-int phenotype (unpublished data), but the
serum concentration of anti-HEL IgM was actually slightly
increased, compared with that found in mice containing no
self-antigen. In contrast, IgM levels in sHEL hosts were as
in HEL-free chimeras. These results show that low levels of
autoantigen-expressing cells do not induce tolerance and
allow autoantibody secretion.
To summarize, our results establish a direct relationship
between the amounts of self-antigen and the fate of the self-
reactive B cells. They show that the developing  -HEL B
cells ignore too little antigen as found in the 0.05% mHEL
chimeras. When the amount of self-antigen increases, au-
toantibody production may even be facilitated, as found in
the 0.5% chimeras. In the 5% mHEL chimeras, the  -HEL
B cells are functionally inactivated (2); that is, they are
present but unable to secrete Igs. At even higher quantities
of HEL, the antigen-specific B cells are deleted. Our find-
ings demonstrate that B cell fate varies according to the
number of mHEL-expressing cells and HEL quantities.
Figure 1. Number of cells recovered in mixed  -HEL/mHEL and
sHEL chimeras. Non-Tg Rag2 /  host mice were irradiated and reconsti-
tuted with a mixture of 50% BM cells from   HEL donors and 50% BM
cells from Rag2 /  mixed with mHEL Tg donors (from left to right: 0,
0.05, 0.5, 5, 10, and 50% BM cells from mHEL donors). (left column) B
cell development in HEL-free control chimeras, which did not receive
cells from mHEL Tg donors. (right) B cell development in mHEL and
sHEL hosts, respectively, reconstituted with 50% BM cells from  -HEL
and 50% BM cells from Rag2 /  donors. (A) Number of B cells
(B220 IgM ) present in the spleen of the mixed chimeras. (B) IgM con-
centrations ( g/ml) in the serum of the mixed chimeras. Each circle rep-
resents one individual chimera and the bar represents the arithmetic mean.
p-values were compared with control HEL chimeras. *, P   0.05. **, P  
0.01. Similar results were obtained in two independent experiments.
Figure 2. Expression of Ig receptors in DIgTg B cells. (A) The dot
plots show the expression of  -TNP heavy chain (identified by the
20.5 Abs) and HEL binding (left) and IgD and IgM expression (right)
by cells from the spleen of  -HEL. -TNP DIgTg mice. The HEL-
specific Tg encodes for both  - and  -chains, whereas the TNP-specific
Tg only encodes for the  -chain and the expression of the IgL and
IgH chains of the two transgenes may not be comparable (reference
19). (B) The histogram shows the fluorescence intensity of the HEL
binding in gated B220  spleen B cells from  -HEL (dark line), DIgTg
(thin line), and control mice (dashed line). (C) HEL binding by single
 -HEL and DIgTg B cells. Spleen cells from  -HEL and DIgTg mice
were incubated with increasing concentrations of [125I]HEL. The
mean cpm is plotted as a function of the HEL concentrations. (D and
E) Competition assays performed by incubating 106 cells with a mix of
[125HEL] 50% and increasing concentrations of unlabeled HEL for  -HEL
cells (D) and DIgTg B cells (E). The value of the association constant
Ka of each cell type, which represents the average affinity constant (the
avidity) of the cell receptors for HEL, is indicated. Identical results were
obtained in two other independent experiments.Gaudin et al. 847
HEL-specific Low Antigen-binding B Cells. Our findings
show that membrane-bound self-antigen, when present in
small quantities, not only allows the survival of self-reactive
B cells but also permits autoantibody secretion. Recent pa-
pers claim that self-reactive B cells expressing two BCRs
can escape deletion and survive in the peripheral pools (16).
To investigate the role of allelic inclusion in B cell selection
by self-antigens, we crossed the MoMD4 ( -HEL) and
MoSP6 ( -TNP) Tg lines and obtained mice bearing two
Ig-heavy and two Ig-light Tg chains in a Rag2 /  genetic
background (20). In the  -HEL. -TNP mice (DIgTg), the
number of peripheral B cells (20   106) is similar to that of
 -HEL mice (20). Although most of the B cells ( 96%)
bind HEL and express the  -TNP heavy chain (Fig. 2 A),
the amount of HEL binding by the bulk population of
DIgTg B cells was reduced to  50% of that of the  -HEL
single BCR B cells (Fig. 2, B and C). The levels of surface
IgM or IgD expression were retained (20). The average
number of HEL molecules bound by the Ig receptors in
the  -HEL B cells was estimated by [125I]HEL binding to
be  2.26   105; that is, 1.13   105 BCRs, whereas in the
B cells from the DIgTg mice, the number of HEL-specific
BCRs was reduced to  5.4   104 (Fig. 2 C). By using
competition assays with unlabeled HEL, we measured the
overall binding strength of the intact HEL-specific B cells
to HEL. The estimated apparent average HEL-binding
avidity of the  -HEL B cells and of the DIgTg B cell pop-
ulations was 7.9   0.1   107 M 1 and 9.2   0.4   107
M 1, respectively (Fig. 2, D and E). These values were sur-
prising because they are well below the nanomolar range
affinity of the original IgG antibody used to make the MD4
Tg mice (2). These divergences are probably due to the fact
that we measured the strength of antigen binding by an in-
tact cell, whereas former works analyzed in vitro interac-
tions between purified antigen and antibody. It is likely
that the cell surface environment and the presence of serum
influence the strength of HEL binding to its IgM/D recep-
tors in the fluid membrane phase. In summary, in DIgTg
mice, the amount of signal that each individual B cell re-
ceives from the HEL-specific antigen receptor is reduced
without interfering with normal B cell development be-
cause the total surface IgM per cell and the total number of
B cells remains the same.
Very Low Quantities of Self-antigen Induced the Positive Selection
of B Cells Expressing Low Numbers of Self-reactive BCRs. We
showed that in DIgTg B cells, the level of surface expres-
sion of the HEL-specific BCR is reduced. Therefore, B
cells from the DIgTg mice may be used to study the inter-
actions of developing low antigen-binding B cells with an-
tigen. They also permit comparison of the effects of higher
(as found in single BCR B cells) with lower levels of BCR
signaling (as found in DIgTg B cells) in B cell selection.
We studied the development of the HEL-specific DIgTg B
cells in the presence of variable quantities of HEL. In
HEL  chimeras, the number of B cells and the serum IgM
levels generated from the B cell–depleted DIgTg BM pre-
cursors (Fig. 3) were identical to those obtained from single
 -HEL Tg BM cells (Fig. 1). This shows that in absence of
HEL, the presence of a second  -TNP Tg BCR does not
interfere with B cell development and selection. In the dif-
ferent mHEL chimeras, we found that the fate of DIgTg B
cells varied with the circulating amounts of HEL and the
number of cells expressing the membrane form of the HEL
self-antigen.
In mHEL hosts, dual IgTg B cells were present in the
BM, but were deleted from the peripheral pool in spite of
their lower HEL binding (Figs. 3, A and B). Consequently,
the IgM levels were below the levels observed in HEL-free
Figure 3. Number of cells recovered in mixed DIgTg/mHEL and sHEL chimeras. Non-Tg Rag2 /  host mice were lethally irradiated and reconstituted
with a mixture of 50% BM cells from DIgTg donors and 50% BM cells from Rag2 /  and mHEL Tg donors mixed at different ratios (from left to right:
0, 5, 25, and 50% BM cells from mHEL donors). (left) B cell development in HEL-free control chimeras, which did not receive cells from mHEL Tg
donors. (right) B cell development in mHEL and sHEL hosts, respectively, reconstituted with 50% BM cells from DIgTg and 50% BM cells from Rag2 / 
donors. (A) Number of B cells (B220 IgM ) present in the BM of the mixed chimeras. (B) Number of B cells (B220 IgM ) present in the spleen of the
mixed chimeras. (C) IgM concentrations ( g/ml) in the serum of the mixed chimeras. Each circle represents one individual chimera and the bar represents
the arithmetic mean. p-values were compared with control HEL  chimeras *, P   0.05. **, P   0.01. (D) Amounts of circulating HEL–IgM immune
complexes detectable in the serum of the mixed DIgTg-sHEL and DIgTg-mHEL chimeras. Values expressed as arbitrary OD units. Similar results were
obtained in two independent experiments.Positive Selection of Self-reactive B Cells 848
chimeras (Fig. 3 C). In the mHEL BM chimeras with de-
creasing quantities of mHEL-expressing cells, the absolute
number of B cells recovered in the BM and spleen and the
IgM levels differed. In the chimeras reconstituted with 25–
50% BM cells from mHEL Tg donors, we recovered 10–20-
fold more mature B cells in the BM and spleen than in the
control HEL  chimeras (Fig. 3 B). In these chimeras, the se-
rum IgM levels were 20-fold higher than those spontane-
ously secreted in the absence of HEL (Fig. 3 C). Interest-
ingly, in sHEL hosts, the number of B cells was also
increased, but the IgM levels were as in HEL-free chimeras
(Fig. 3, A–C). In the chimeras reconstituted with very few
mHEL Tg BM cells (5%), the number of B cells was lower,
but the IgM concentrations remained high (Fig. 3 C). In the
serum of the different mHEL chimeras, we also detected the
presence of soluble HEL–IgM immune complexes (Fig. 3
D). In summary, these findings demonstrate that low quanti-
ties of self-antigen allow the survival and accumulation of B
cells expressing lower densities of self-reactive BCRs. More-
over, these cells are functionally active because they retain
anti-IgM responsiveness in vitro (unpublished data), and a
fraction of these cells is activated and secretes self-reactive
IgM that forms circulating immune complexes with HEL.
We found that most ( 70%) of the DIgTg HEL-spe-
cific B cells present in the BM of the mHEL, sHEL, and
HEL-free chimeras express 493, a surface marker that de-
fines populations of newly produced immature B cells
(Fig. 4 A; reference 27). This observation indicates that the
accumulation of the HEL-specific self-reactive B cells in
the BM of the HEL  chimeras occurs early at the imma-
ture B cell stage and is not just the result of the local BM
accumulation of mature recirculating B cells that do not
express 493 (27). In the spleen, the mature B cells that ac-
cumulate in the presence of small amounts of HEL are
small resting cells (CD5 , CD43 , and CD69 ; not de-
picted), of which most lost expression of 493 (Fig. 4 A).
They predominantly express a transitional CD23loCD21lo-int
or mature CD23hiCD21int-hi phenotype (Fig. 4 B; refer-
ence 28) that differs from the CD23loCD21hi phenotype
characteristic of activated marginal zone B cells (29). The
fraction of marginal zone type B cells was identical in the
different HEL  and HEL  chimeras (11–13% of the spleen
B cells; Fig. 4 B).
We studied the accumulation of BrdU-labeled B cells in
the BM and spleen of HEL-free and HEL  chimeras. At day
1 after BrdU administration, the fraction of BrdU-labeled B
cells in the BM of the HEL  chimeras was identical to that
observed in the HEL-free mice (Table II and Fig. 4 C),
whereas at day 3, it was higher (Table II). Taking into ac-
count the 10-fold increase in the number of BM B cells (Ta-
Figure 4. Phenotype of the DIgTg
B cells developed in the absence or
presence of small amounts of self-
HEL. (A) Dot plots show HEL bind-
ing and 493 expression by gated
B220  BM (left and middle) and
spleen (right) cells developed in the
absence (left, control) and in the
presence (middle and right) of self-
mHEL. (B) Dot plots show CD21
and CD23 expression by gated
B220  HEL-binding spleen B cells
developed in the absence (left) and
presence of self-HEL (right). Total B
cell numbers are shown in Fig. 3 (A
and B). (C) Dot blots show the frac-
tion of BrdU-labeled DIgTg B cells
(gated B220 IgD ) in the BM and
spleen 1 or 3 d after BrdU adminis-
tration in HEL-free and HEL  chi-
meras. The fraction of BrdU  cells
was defined using as negative controls
the BrdU staining of cells from non-
injected mice. Similar results were
obtained in three independent chi-
meras in each group and each time
point. It should be noted that, due to
the usage of BCR Tg mice, the frac-
tion of BM pre–B cells was negligible
and all B cells express the IgD trans-
gene. B cells were preferentially
gated by IgD expression because it
was found that the IgD staining re-
sisted better to fixation and DNase
treatment. These mixed BM chimeras
also contained in their BM a fraction
of pro-B cells from the non-Tg Rag-
deficient BM inoculum.Gaudin et al. 849
ble II), this demonstrates an effective increase in the daily
BM B cell production and accumulation (at day 3) in the
HEL  chimeras. At day 1 after BrdU administration, 6.7%
of the spleen B cells in the HEL-free chimeras were BrdU ,
whereas in the HEL  chimeras, only 1.8% of the B cells
were BrdU  (Table II and Fig. 4 C), indicating that these
cells are not actively proliferating in the presence of the self-
antigen. At day 3 after BrdU administration, the fraction of
BrdU-labeled spleen B cells did not differ significantly in the
HEL-free and HEL  chimeras (Table II and Fig. 4 C). Con-
sidering the absolute number of spleen B cells observed in
the types of chimeras, these findings suggest that the fraction
of newly produced B cells that accumulate in the mature B
cell pool is higher in the presence of self-HEL. In conclu-
sion, these observations suggest that the presence of HEL
promotes the production of increased B cell numbers in the
BM and their subsequent accumulation in the spleen (i.e.,
the positive selection of early developing B cells, rather than
the proliferation of mature B cells; reference 30).
Table II. Accumulation of BrdU  DIgTg HEL-specific B Cells 
Developing in the Presence or Absence of HEL Neoantigen
BM SPL
HEL free HEL  HEL free HEL 
No. cells
( 106)a
0.24   0.1 3.96   0.8c 0.5   0.1 6.35   2.4d
% BrdU b day 1 44.1   1.98 50.7   3 6.7   0.35 1.8   0.07c
day 3 35.7   10.2 76.1   13.6c 7.9   3.3 9.5   0.6
Results show the mean   SE of three to six mice.
aThe number of B cells in the BM and spleen of HEL-free and HEL 
chimeras. 
bThe fraction of BrdU-labeled DIgTg B cells (gated B220 IgD ) in
the BM and spleen 1 or 3 d after BrdU administration in HEL-free and
HEL  chimeras. 
cP   0.01.
dP   0.05. 
Figure 5.  (A) Dot plots show HEL binding and  -TNP IgH expression by gated B220  BM (left) and spleen cells (right) from control chimeras
reconstituted with BM cells from DIgTg (50%) in the absence of HEL (control) and in chimeras reconstituted with 25% BM cells from mHEL donors.
(B) Histogram shows the fluorescence intensity of the HEL binding (left) and IgM (middle) and IgD (right) staining, in gated B220  spleen B cells from
control (dark line) and the DIgTg-mHEL (25%) chimeras (thin line). Note that in these HEL-selected cells with lower HEL binding, the total cell surface
expression of IgM receptors is retained (right histogram), which excludes BCR internalization by bound HEL. (C) HEL binding by DIgTg B cells
developed in the absence or in the presence of 25% mHEL chimeras. Spleen cells were incubated with increasing concentrations of [125I]HEL. Results
plot the mean cpm as a function of the HEL concentrations. (D) Shows the competition assay done by incubating 106 DIgTg B cells selected in 25%
mHEL chimeras with a mix of [125HEL]50% and increasing concentrations of unlabeled HEL. The value of the association constant Ka, which represents
the average affinity constant (the avidity) of the cell receptors for HEL, is indicated.Positive Selection of Self-reactive B Cells 850
We found that the selected B lymphocytes showed a
unique phenotype that developed in the presence but not in
the absence of self-HEL. They were all HEL-specific self-
reactive cells that partially or completely lost expression of
the  -TNP IgH chain (Fig. 5 A). The density of the HEL-
binding receptors among the DIgTg B cells developing in
the presence of self-HEL was 8.8   103 BCRs; that is, it
was one sixth of DIgTg B cells developing in the absence of
HEL (5.4   104; Fig. 5, B and C). Our estimate of the
HEL-specific BCR number per cell was not hindered by
receptor blockade by self-antigen bound in vivo because we
used an indirect staining method to identify the HEL-bind-
ing B220  B cells. The cells were first incubated in the pres-
ence of soluble HEL and counterstained thereafter with a
labeled anti-HEL monoclonal antibody recognizing a dif-
ferent HEL epitope. Thus, the staining shown in Fig. 5 B
truly reflects the numbers of HEL-binding receptors/B cells
because all receptors occupied by HEL either bound in vivo
or after the in vitro preincubation step must be recognized
by the second step anti-HEL–labeled antibody. By directly
incubating the spleen cells of the different chimeras with the
labeled anti-HEL Abs in the absence of the in vitro preincu-
bation step with HEL, we also failed to stain any B220  B
cells in the spleen cells (unpublished data), thus demonstrat-
ing that in vivo, HEL does not occupy their BCRs. The
same technical procedure labeled the HEL-producing
B220  Tg cells present in the mHEL chimeras. Moreover,
the total cell surface expression of IgM and IgD receptors in
the HEL-selected B cells with lower HEL-binding is re-
tained (Fig. 5 B), which also excludes BCR internalization
mediated by in vivo binding of HEL. Because we could ex-
clude receptor blockade and internalization, we studied the
inhibition of 125HEL binding with cold HEL to assess the
average strength of HEL binding by the population of B
cells selected in presence of self-HEL. In this case, we found
that the estimated apparent HEL-binding avidity of the
whole DIgTg B cells is  2.0   0.1   107 M 1; that is, it’s
20–25% that of the DIgTg B cells developing in absence of
HEL (Fig. 5 D). It was previously shown that, indepen-
dently of the BCR affinity, developing B cells are highly
sensitive to the deletion mechanisms imposed by membrane
bound self-antigens (31, 32). Our results show that this is
not always the case. We found that the antigen load strictly
determines the fate of the low avidity self-reactive B cells.
In conclusion, we found that low quantities of HEL self-
antigen positively selected a population of self-reactive B
cells that express lower densities of self-reactive BCRs and
show a lower Ka binding for HEL. These self-reactive B
cells accumulate in the BM and periphery, and a fraction of
them is activated and secretes self-reactive IgMs that form
circulating immune complexes with the HEL self-antigen.
Discussion
In this investigation, we studied the selection of homo-
geneous populations of self-reactive B cells differing by
their capacity to bind high and low quantities of antigen in
BM chimeras expressing different amounts of self-antigen.
These studies revealed novel aspects of B cell selection by
self-antigens. First, we demonstrated that membrane-
bound self-antigens do not always lead to B cell deletion
(31, 32). Different types of B cell tolerance could be in-
duced depending of the quantity of self-antigen. Negative
selection of B cells expressing a high-affinity HEL-specific
self-reactive BCR was only achieved when the cells
expressing membrane-bound self-antigen (mHEL) were
present in high amounts. Decreasing the numbers of
mHEL cells allowed the survival of the HEL-specific B
cells, but these cells were functionally impaired. Finally, at
even lower HEL amounts, B cells expressing high-affinity
self-reactive receptors did not encounter the mHEL  he-
matopoietic cells, which are discretely distributed, and es-
caped deletion. Second, by forcing BCR allelic inclusion,
we modified the fate of the self-reactive B cells. Allelic in-
clusion allowed B cells to escape deletion and permitted the
increased accumulation (positive selection) and activation
of the self-reactive B cells. Indeed, by studying the selec-
tion of DIgTg HEL-specific B cells, we observed that re-
ducing the number of cells expressing and releasing self-
antigen induced a 10–20-fold increase in the number of
peripheral B cells. It also induced an increase in the serum
IgM values, which were 20-fold higher than those released
“spontaneously” in absence of HEL and formed detectable
circulating HEL–IgM immune complexes. Interestingly, in
sHEL hosts expressing exclusively soluble HEL, the posi-
tive selection of the self-reactive DIgTg B cells followed
the same rules, but was not accompanied by increasing se-
rum IgM levels.
The unique phenotype of the selected cells, and the in-
creased number of mature B cells observed only in mice
expressing but not lacking HEL, concord with a definition
of positive selection in which self-reactive B cells are gen-
erated, maintained, and accumulated based on their BCR
auto reactivity; that is, they are induced by the presence of
self-antigen (8, 30). We found that the B cells selected by
small quantities of self-antigen differed from those develop-
ing in absence of self-antigen. In absence of self-antigen,
spleen DIgTg B cells express high levels of HEL-specific
BCRs and coexpress the  -TNP heavy chain. In the pres-
ence of self-HEL, the selected DIgTg B cells maintained
total surface IgM and IgD levels, but the density of expres-
sion of the HEL-binding receptors was one sixth that of
control DIgTg B cells, and the cells did not express the
 -TNP IgH chain. The average avidity of HEL binding in
the population of DIgTg B cells selected in presence of
self-HEL was approximately fivefold lower than that of the
B cells developing in absence of HEL. This observation
contradicts previous papers showing that the expression of
low affinity ligands resulted always in the complete deletion
of self-reactive B cells (31, 32). However, in these latter
works, the development of the self-reactive B cells was in-
vestigated only in the presence of high levels of self-antigen
ubiquitously distributed, and the number of the antigen-
specific self-reactive BCRs was fixed (31–33). Moreover,Gaudin et al. 851
by comparing the fraction and the absolute number of
BrdU-labeled cells in the BM and spleen, our findings
show that the presence of HEL promotes an increased pro-
duction of BM B cells and the accumulation of self-reactive
B cells in the BM and spleen. In the BM,  70% of the
HEL-specific selected DIgTg B cells retained the 493 
phenotype characteristic of newly formed B cells (27). In
the spleen of the HEL  chimeras, the fraction of BrdU  B
cells 1 d after BrdU administration was low ( 2%), indicat-
ing that they were not actively proliferating in the presence
of self-antigen. Thus, the increased number of DIgTg
HEL-specific B cells did not result from the proliferation of
mature cells. The selected B cells were small resting non-
cycling CD69  cells, which showed a late transitional 493 
or mature CD23hiCD21int phenotype (28) that differs from
the CD23loCD21hi phenotype characteristic of the acti-
vated marginal zone B cells (29). This observation confirms
that production of autoantibodies does not necessarily cor-
relate with an increase in the fraction of marginal zone B
cells (14, 16, 34).
Self-reactive B cells are generally removed at different
checkpoints during ontogeny and BM B cell development
(1). In the spleen of neonatal mice, there is a unique set of
polyspecific self-reactive B cells expressing Vh7183 genes
that is rare in adult mice (35). In adult mice, BM B cell de-
velopment partially recapitulates B cell ontogeny, and im-
mature B cells also overexpress Vh7183 genes (36). Re-
cently, it has been shown that early immature human B
cells also displayed self-reactive and polyreactive specifici-
ties, which are lost during B cell differentiation (37). Insuf-
ficient checkpoint regulation may allow complete matura-
tion of self-reactive B cells. It has been shown that low
levels of BCR surface expression and signaling allowed
self-reactive B cells escape deletion (38). Reduced receptor
signaling in CD45-deficient mice rescued high avidity self-
reactive B cells (39). Down-regulation of surface IgM or
BCR expression (14, 15) allowed survival of self-reactive B
cells. Dual receptor B cells, in which the expression of a
self-reactive BCR was diluted by the presence of a second
BCR escaped deletion (16). In the absence of self-reactiv-
ity, B cells escape checkpoint regulation and can incorpo-
rate the immature peripheral B cell pool. On the other
hand, the presence of a self-antigen has also been shown to
positively select and expand a small number of self-reactive
Tg PerC B1 B cells with production of self-reactive Igs (8,
40). However, PerC B cells and spleen CD5  B1 B cells
were absent in the chimeras reconstituted with  -HEL or
DIgTg BM cells (unpublished data). We hypothesize that
the DIgTg BM precursors generate and provide a wide
choice of B cells expressing different densities (numbers) of
the self-reactive  -HEL receptors. HEL self-antigen, when
present in low quantities, promotes the selection and ex-
pansion of the pool of B cells expressing fewer HEL-spe-
cific receptors and with a lower overall HEL-binding
strength. The lack of expression of the  -TNP heavy chain
by the positively selected B cells is intriguing. One may
note that in the DIgTg mice, the presence of a second
 -TNP Tg BCR did not interfere with B cell develop-
ment and selection; the number of B cells in the DIgTg
mice and BM chimeras were identical to those in the  -HEL
mice and chimeras. However, MoSP6 mice lack peripheral B
cells, a phenomenon that is attributed to early B cell dele-
tion due to their anti-self DNA specificity (41). Moreover,
the association of the  -TNP heavy chain with other Ig-
light chains still retains an anti-DNA specificity (20). How-
ever, DIgTg B cells can dilute anti-DNA receptor by coex-
pressing two Tg heavy-chains, and thus escape deletion. In
the presence of both DNA and HEL self-antigens, only the
DIgTg B cells that express low numbers of HEL-specific
receptors and simultaneously do not express a DNA-spe-
cific receptor can be selected. Cells that do not express
the  -TNP heavy chain and retain the expression of the
 -HEL heavy chains (  and  ) predominantly associated
with the  -TNP light chain. Thus, the selected self-reac-
tive B cells dilute the number of HEL-specific BCRs by
the coexpression of the  -TNP light chains. The presence
of hybrid receptors composed of  -HEL IgH/ -HEL IgL
chains and  -HEL IgH/ -TNP IgL chains may explain the
lower HEL-binding avidity of the selected B cells. In sum-
mary, the positively selected self-reactive DIgTg B cells
selectively reduce self-antigen signaling by diluting the self-
reactive BCR, while, in contrast with the findings of previ-
ous papers (14, 15), maintaining total IgM and IgD levels.
Dilution of a self-reactive BCR by light chain coexpression
represents a novel form of “receptor editing” in which B
cells in the presence of a self-antigen replace a self-reactive
BCR by a second nonself-reactive BCR with a different
specificity (42–46). The receptor editing processes de-
scribed thus far (6, 42–45) require new Ig chain rearrange-
ment, which cannot occur in the DIgTg Rag2 /  mice. It
would be of interest to find out whether the silencing of
the   -TNP IgH chain is transcriptional or translational.
Overall, our findings suggest that low-avidity single BCR
cells may be positively selected and activated if the number
of BCRs engaged is low (i.e., when in the presence of
small amounts of self-antigen).
In conclusion, the present work demonstrates for the
first time that low quantities of self-antigen can promote
the positive selection of conventional self-reactive B cells.
By using a novel experimental strategy to study the fate of a
unique population of B cells developing in BM chimeras
reconstituted with a reduced fraction of B cell precursors
and expressing different quantities of self-antigens, we have
revealed events of B cell selection by self-antigens that are
likely diluted and undetectable in normal intact mice. By
directly measuring the strength of HEL binding through
whole self-reactive B cells, we show that the fate of a de-
veloping B cell is dependent on the number of surface
BCRs engaged and on the overall avidity of the Ag-specific
cell (28, 38) rather than on the affinity of individual BCRs.
The present findings have broader implications. First, they
emphasize the role of BCR allelic exclusion. Compared
with single BCR B cells, dual BCR B cells have a higher
probability of expressing variable densities of self-reactivePositive Selection of Self-reactive B Cells 852
receptors and, therefore, have an increased likelihood to
generate cells with an avidity permissive to positive selec-
tion, activation, and production of self-reactive antibodies.
Therefore, BCR allelic exclusion is required to minimize
the selection of dual receptor self-reactive B cells. Second,
they indicate that B cell homeostasis may be regulated by
the availability of BCR ligands. By varying the quantities of
HEL, we were able to modify the number of peripheral B
cells, indicating that antigen may function either as a re-
source or as a surrogate resource; i.e., a resource not in it-
self in limiting supply, but which is competed for because
of the access it provides to some other resource that is or
may become limited in supply (10). Finally, they suggest
that natural serum IgMs may be the result of the activation
of low avidity self-reactive B cells, thus explaining the pres-
ence in the serum of normal individuals of a relatively high
frequency of autoantibodies.
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